ACQUIRED NEUROMYOTONIA/ ISAAC’S SYNDROME Acquired Neuromyotonia/Isaac’S Syndrome Stacey Jankelowitz July 2012

ACQUIRED NEUROMYOTONIA/ ISAAC’S SYNDROME Acquired Neuromyotonia/Isaac’S Syndrome Stacey Jankelowitz July 2012

ACQUIRED NEUROMYOTONIA/ ISAAC’S SYNDROME Acquired Neuromyotonia/Isaac’s Syndrome Stacey Jankelowitz July 2012 Definition: Acquired Neuromyotonia is an immune disorder that presents with cramps and fasciculations (twitching or flickering of muscles) due to peripheral nerve hyperexcitability. The condition can affect all limb and trunk muscles. Speech can be involved and results in intermittent speech difficulties. The autonomic nervous system can also be affected and this may present as gastrointestinal symptoms with bloating, burping and altered bowel habits or excessive sweating. Patients may also complain of fatigue. Aetiology: The cause of acquired neuromyotonia is not known. An antibody to voltage gated K channels can be found in the serum of most individuals with the condition. Clinical Examination: Patients have normal muscle bulk and tone. Muscle power is normal. Cramps may be easily elicited with voluntary activity. Fasciculation of a variety of muscles may be seen and these may flit from one muscle to another. Diagnosis: The diagnosis is one of exclusion. 1) Neurophysiological tests are useful as they show fasciculation potentials with after discharges. Despite the fasciculations, needle tests of the muscle (EMG) do not show any other signs of denervation in the muscles. Myotonic discharges (distinctive bursts of muscle activity) can be seen on needle EMG. Sensory and motor nerve conduction tests are normal. 2) Voltage gated K channel antibodies may be present in the patient’s blood. Treatment: Most patients respond well to treatment but treatment is usually needed indefinitely. 1) IvIg: Intravenous immunoglobulin is made from pooled human serum or can be mad in the laboratory. This contains many different proteins that are thought to bind with disease causing antibodies and relieve the symptoms. Patients receive intravenous infusions of the IvIg at 4 weekly intervals. 2) Plasma Excahnge: As this is more invasive and costly treatment, plasma exchange is reserved as second line treatment. This involves removing the patient’s blood, washing it and returning the blood cells with added fluid to the patient (similar to dialysis machines for kidney disease). 3) Symptomatic treatment for the cramps is given in the form of anti-epileptic drugs such as carbamazepine. Prognosis: Occasionally patients go in to a spontaneous remission but most patients require ongoing treatment and are able to continue a normal life. .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us